Evidence map›Paper›PMID 25227228›Full record

ArticleG3 (Bethesda, Md.)2014

The genome of the chicken DT40 bursal lymphoma cell line.

János Molnár, Ádám Póti, Orsolya Pipek, Marcin Krzystanek, Nnennaya Kanu, Charles Swanton, Gábor E Tusnády, Zoltan Szallasi, István Csabai, Dávid Szüts

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A pathway for mitotic chromosome formation.Science (New York, N.Y.) · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

János MolnárInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Hungary.
Ádám PótiInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Hungary.
Orsolya PipekDepartment of Physics of Complex Systems, Eötvös Loránd University, H-1117 Budapest, Hungary.
Marcin KrzystanekCenter for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, DK-2800 Lyngby, Denmark.
Nnennaya KanuCancer Research UK London Research Institute, London, WCA2 3PX, United Kingdom.
Charles SwantonCancer Research UK London Research Institute, London, WCA2 3PX, United Kingdom.
Gábor E TusnádyInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Hungary.
Zoltan SzallasiCenter for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, DK-2800 Lyngby, Denmark Children's Hospital Informatics Program at the Harvard-Massachusetts Institutes of Technology Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, MA 02115.
István CsabaiDepartment of Physics of Complex Systems, Eötvös Loránd University, H-1117 Budapest, Hungary.
Dávid SzütsInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Hungary szuts.david@ttk.mta.hu.
Cancer Research UK · GBEötvös Loránd University · HUHungarian Academy of Sciences · HUInstitute of Molecular Life Sciences · HUHarvard–MIT Division of Health Sciences and Technology · USTechnical University of Denmark · DK

Funding

Cancer Research UK 17786Cancer Research UK 19310
6 · The paper itself

Abstract

The chicken DT40 cell line is a widely used model system in the study of multiple cellular processes due to the efficiency of homologous gene targeting. The cell line was derived from a bursal lymphoma induced by avian leukosis virus infection. In this study we characterized the genome of the cell line using whole genome shotgun sequencing and single nucleotide polymorphism array hybridization. The results indicate that wild-type DT40 has a relatively normal karyotype, except for whole chromosome copy number gains, and no karyotype variability within stocks. In a comparison to two domestic chicken genomes and the Gallus gallus reference genome, we found no unique mutational processes shaping the DT40 genome except for a mild increase in insertion and deletion events, particularly deletions at tandem repeats. We mapped coding sequence mutations that are unique to the DT40 genome; mutations inactivating the PIK3R1 and ATRX genes likely contributed to the oncogenic transformation. In addition to a known avian leukosis virus integration in the MYC gene, we detected further integration sites that are likely to de-regulate gene expression. The new findings support the hypothesis that DT40 is a typical transformed cell line with a relatively intact genome; therefore, it is well-suited to the role of a model system for DNA repair and related processes. The sequence data generated by this study, including a searchable de novo genome assembly and annotated lists of mutated genes, will support future research using this cell line.

Indexed as

Gene Expression Regulation, NeoplasticGenomeAnimalsCell Line, TumorChickensDNA HelicasesGene DeletionKaryotypeLymphomaMutagenesis, InsertionalPhosphatidylinositol 3-KinasesPolymorphism, Single NucleotideProto-Oncogene Proteins c-mycDNA HelicasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-mycchicken genomeDT40gene targetingsingle nucleotide polymorphismtumor suppressor gene

Identifiers

PMID25227228
PMCPMC4232548
OpenAlexW2164925963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.